Monday, February 26 - Glaucoma & Dry Eye
​
Morning Sessions 
Moderator Christina Prescott, MD, PhD

​

7:45-7:50 AM: Course Introduction | Ronald Frenkel, MD
7:50-8:10 AM: MIGS Update | David Goldman, MD
8:10-8:25 AM: Open Discussion
8:25-9:00 AM: MIGS Guided Discussion | Steven Vold, MD
​

Afternoon Sessions
Moderator Ronald Frenkel, MD

​

4:30-4:50 PM: AI in Glaucoma | Steven Vold, MD
4:50-5:05 PM: Open Discussion
5:05-5:30 PM: Dry Eye Management in 2024 | Christina Prescott, MD, PhD
5:30-5:55 PM: Open Discussion
5:55-6:45 PM: Dry Eye Guided Discussion | David Goldman, MD
​

​

Tuesday, February 27 - Cataract
​
Morning Sessions
Moderator David Goldman, MD

​

7:45-8:05 AM: IOL Update 2024 | David Goldman, MD
8:05-8:25 AM: Open Discussion
8:25-8:45 AM: Non-ocular Factors Influencing Intraocular Lens Selection | Christina Prescott, MD, PhD
8:45-9:00 AM: Open Discussion
​
Afternoon Sessions
Moderator Steven Vold, MD

​

4:30-5:00 PM: Kelman Lecture: Refractive Cataract Surgery | Christina Prescott, MD, PhD
5:00-5:25 PM: Open Discussion
5:25-5:45 PM: Objective and Subjective Outcomes of EODF IOLs | Christina Prescott, MD, PhD
5:45-6:00 PM: Open Discussion
6:00-6:20 PM: Cataract Surgery After Refractive Surgery | Christina Prescott, MD, PhD
6:20-6:45 PM: Open Discussion
​

​

Wednesday, February 28 - Retina
​
Morning Sessions
Moderator Ronald Frenkel, MD

​

7:45-7:50 AM: Course Retina Introduction | Ronald Frenkel, MD
7:50-8:10 AM: Improving Diagnostic Skills in Retinal Diseases | Lee Jampol, MD
8:10-8:25 AM: Open Discussion
8:25-8:45 AM: Central Serous Chorioretinopathy | Richard Spaide, MD
8:45-9:00 AM: Open Discussion
​
Afternoon Sessions
Moderator Daniela Ferrera, MD, PhD

​

4:30-4:50 PM: AI: Deep Learning to Predict Geographic Atrophy Progression 
4:50-5:00 PM: Open Discussion
5:00-5:20 PM: AI for Clinical Trials in Retinal Disease | Daniela Ferrera, MD, PhD
5:20-5:30 PM: Open Discussion
5:30-6:00 PM: Norton Lecture: Clinical Trials Moving Forward | Charles Wykoff, MD, PhD
6:00-6:10 PM: Open Discussion
6:10-6:45 PM: Panel Discussion on Vein Occlusions | Michael Stewart, MD
​Panelists: Daniela Ferrera, MD, PhD; Ronald Frenkel, MD; Lee Jampol, MD; Carl Regillo, MD; Richard Spaide, MD; Charles Wykoff, MD, PhD
​
Special Events
6:45-7:30 PM: Cocktail Party (Everyone is welcome. Please RSVP here.)

​​

​

​

Thursday, February 29 - Advanced Retina Topics

​

Morning Sessions
Moderator Richard Spaide, MD

​

7:45-8:15 AM: AI Featuring Large Language Models | Richard Spaide, MD
8:15-8:30 AM: Open Discussion
8:30-8:50 AM: Retinal Non-Perfusion | Charles Wykoff, MD, PhD
8:50-9:00 AM: Open Discussion
​
Afternoon Sessions
Moderator Charles Wykoff, MD, PhD

​

4:30-4:50 PM: DRCR Update | Lee Jampol, MD
4:50-5:05 PM: Open Discussion
5:05-5:25 PM: Pathways to Geographic Atrophy | Richard Spaide, MD
5:25-5:40 PM: Open Discussion
5:40-6:00 PM: GA Therapy | Ronald Frenkel, MD
6:00-6:45 PM: GA Therapy Panel Discussion
Panelists: Daniela Ferrera, MD, PhD; Lee Jampol, MD; Carl Regillo, MD; Richard Spaide, MD; Michael Stewart, MD; Charles Wykoff, MD, PhD
​

 

Friday, March 1 - Closing Sessions on Retina
​
Morning Sessions
Moderator Lee Jampol, MD

​

7:45-8:15 AM: Machemer Lecture: New and Emerging nAMD Treatments | Carl Regillo, MD
8:15-8:30 AM: Open Discussion
8:30-8:45 AM: Home OCT  | Lee Jampol, MD
8:45-9:00 AM: Open Discussion
​
Afternoon Sessions
Moderator Michael Stewart, MD

​

4:30-4:50 PM: The Evolving Story of Fluid in nAMD Treatment | Michael Stewart, MD
4:50-5:05 PM: Open Discussion
5:05-5:25 PM: AI for Clinical Trials in Retinal Disease | Daniela Ferrera, MD, PhD
5:25-5:35 PM: Open Discussion
5:35-5:55 PM: PVR Surgery: Techniques and Pearls | Carl Regillo, MD
5:55-6:05 PM: Open Discussion
6:05-6:30 PM: Investor Led Transactions | Christopher Anderson
6:30-6:45 PM: Open Discussion
​

 

​
The End